In the child psychiatric clinic of the University Medical Center Hamburg-Eppendorf (https://www.uke.de/kliniken-institute/kliniken/kinder-und-jugendpsychiatrie-psychotherapie-und-psychosomatik/index.html), Director Prof. Dr. Schulte-Markwort diagnoses Timo, the son of founder Ingo Krause, with ADHD for the first time.
In order to enable him to attend school, the first medication with the active substance methylphenidate is administered. However, the medication is only available in coarse dosage increments, resulting in fluctuating results. This results in a more difficult therapy, which also has a massive impact on the family situation.
This unacceptable allocation of the medication by breaking the tablets became the birth of PrivMed®. A better technical solution had to be found.
At the company www.kg-pharma.de of the founder Ingo Krause, which has been manufacturing R&D tablet presses since 2006, thoughts now began to develop an ultra-compact tablet press for the production of completely personalized medication.
Today, Timo is a cheerful teenager who has just entered the 9th grade.